Insider Buying: PureTech Health (LON:PRTC) Insider Purchases £37,462.39 in Stock

PureTech Health plc (LON:PRTC) insider Michele Holcomb bought 31,481 shares of the company’s stock in a transaction that occurred on Wednesday, July 8th. The stock was purchased at an average cost of GBX 119 per share, with a total value of £37,462.39.

PureTech Health Trading Up 1.6%

Shares of PRTC stock opened at GBX 120 on Thursday. The company has a debt-to-equity ratio of 6.33, a quick ratio of 2.51 and a current ratio of 6.59. The stock has a fifty day simple moving average of GBX 129.88 and a two-hundred day simple moving average of GBX 127.13. The firm has a market capitalization of £292.10 million, a PE ratio of -2.61 and a beta of 0.79. PureTech Health plc has a 52-week low of GBX 104.71 and a 52-week high of GBX 148.

About PureTech Health

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia.